REFERENCES
1. Tarantini G, Mojoli M, Windecker S, et al. Prevalence and impact of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the SOURCE XT prospective multicenter registry. JACC Cardiovasc Interv 2016;9:937-46.
2. Chandrasekhar J, Dangas G, Yu J, et al. STS/ACC TVT Registry. Sex-based differences in outcomes with transcatheter aortic valve therapy: TVT registry from 2011 to 2014. J Am Coll Cardiol 2016;68:2733-44.
3. Thyregod HG, Steinbrüchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol 2015;65:2184-94.
4. Iung B, Algalarrondo V. Atrial fibrillation and aortic stenosis: complex interactions between 2 diseases. JACC Cardiovasc Interv 2020;13:2134-6.
5. Arora S, Vemulapalli S, Stebbins A, et al. The prevalence and impact of atrial fibrillation on 1-year outcomes in patients undergoing transcatheter mitral valve repair: results from the society of thoracic surgeons/american college of cardiology transcatheter valve therapy registry. JACC Cardiovasc Interv 2019;12:569-78.
6. Alexiou C, Doukas G, Oc M, et al. The effect of preoperative atrial fibrillation on survival following mitral valve repair for degenerative mitral regurgitation. Eur J Cardiothorac Surg 2007;31:586-91.
7. Grigioni F, Benfari G, Vanoverschelde JL, et al. MIDA Investigators. Long-term implications of atrial fibrillation in patients with degenerative mitral regurgitation. J Am Coll Cardiol 2019;73:264-74.
8. Levy F, Garayalde E, Quere JP, Ianetta-Peltier M, Peltier M, Tribouilloy C. Prognostic value of preoperative atrial fibrillation in patients with aortic stenosis and low ejection fraction having aortic valve replacement. Am J Cardiol 2006;98:809-11.
9. Ngaage DL, Schaff HV, Barnes SA, et al. Prognostic implications of preoperative atrial fibrillation in patients undergoing aortic valve replacement: is there an argument for concomitant arrhythmia surgery? Ann Thorac Surg 2006;82:1392-9.
10. Stortecky S, Buellesfeld L, Wenaweser P, et al. Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv 2013;6:77-84.
11. Ahmed R, Sawatari H, Deshpande S, et al. Impact of atrial fibrillation on outcomes of aortic valve implantation. Am J Cardiol 2022;163:50-7.
12. Dvir D, Webb JG, Bleiziffer S, et al. Valve-in-Valve International Data Registry Investigators. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA 2014;312:162-70.
13. Moore BJ, White S, Washington R, Coenen N, Elixhauser A. Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ elixhauser comorbidity index. Med Care 2017;55:698-705.
14. Shroyer AW, Coombs LP, Peterson ED, et al. The society of thoracic surgeons: 30-day operative mortality and morbidity risk models. The Annals of Thoracic Surgery 2003;75:1856-65.
15. Shahian DM, Silverstein T, Lovett AF, Wolf RE, Normand SL. Comparison of clinical and administrative data sources for hospital coronary artery bypass graft surgery report cards. Circulation 2007;115:1518-27.
16. Ebrahimi R, Lynch KE, Beckham JC, et al. Association of posttraumatic stress disorder and incident ischemic heart disease in women veterans. JAMA Cardiol 2021;6:642-51.
17. Bradley DR, Cutcomb S. Monte Carlo simulations and the chi-square test of independence. Behavior Research Methods & Instrumentation 1977;9:193-201.
18. Grover FL, Shroyer AL, Hammermeister KE. Calculating risk and outcome: the veterans affairs database. Ann Thorac Surg 1996;62:S6-11.
20. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
21. Khoury H, Ragalie W, Sanaiha Y, et al. Readmission after surgical aortic valve replacement in the United States. Ann Thorac Surg 2020;110:849-55.
22. Doshi R, Taha M, Dave M, Desai R, Gullapalli N. Sex differences in 30-day readmission rates, etiology, and predictors after transcatheter aortic valve replacement. Indian Heart J 2019;71:291-6.
23. Onorati F, Quintana E, El-Dean Z, et al. Aortic valve replacement for aortic stenosis in low-, intermediate-, and high-risk patients: preliminary results from a prospective multicenter registry. J Cardiothorac Vasc Anesth 2020;34:2091-9.
24. Holmes DR Jr, Brennan JM, Rumsfeld JS, et al. STS/ACC TVT Registry. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA 2015;313:1019-28.
25. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008;51:802-9.
26. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the framingham study. Stroke 1991;22:983-8.
27. Taylor NE, O’ Brien S, Edwards FH, Peterson ED, Bridges CR. Relationship between race and mortality and morbidity after valve replacement surgery. Circulation 2005;111:1305-12.
28. Minha S, Barbash IM, Magalhaes MA, et al. Outcome comparison of African-American and caucasian patients with severe aortic stenosis subjected to transcatheter aortic valve replacement: a single-center experience. Catheter Cardiovasc Interv 2015;85:640-7.
29. Alqahtani F, Aljohani S, Almustafa A, et al. Comparative outcomes of transcatheter aortic valve replacement in African American and caucasian patients with severe aortic stenosis. Catheter Cardiovasc Interv 2018;91:932-7.
30. Hernandez-Suarez DF, Ranka S, Villablanca P, et al. Racial/Ethnic disparities in patients undergoing transcatheter aortic valve replacement: insights from the healthcare cost and utilization project’s national inpatient sample. Cardiovasc Revasc Med 2019;20:546-52.
31. Martin E, Dagenais F, Voisine P, et al. Surgical aortic valve replacement outcomes in the transcatheter era. J Thorac Cardiovasc Surg 2015;150:1582-8.
32. Jiménez-García R, Perez-Farinos N, Miguel-Díez J, et al. National trends in utilization and in-hospital outcomes of surgical aortic valve replacements in spain, 2001-2015. Braz J Cardiovasc Surg 2020;35:65-74.
33. Capodanno D, Barbanti M, Tamburino C, et al. OBSERVANT Research Group. A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 2014;113:1851-8.
34. Bianco V, Kilic A, Gleason TG, et al. Long-term hospital readmissions after surgical vs. transcatheter aortic valve replacement. Ann Thorac Surg 2019;108:1146-52.
35. Hirji SA, Cote C, Lee J, et al. Transcatheter vs. surgical aortic valve replacement in patients with interstitial lung disease. J Card Surg 2020;35:571-9.
36. Kadri AN, Bernardo M, Assar SZ, Werns S, Abbas AE. Surgical versus transcatheter aortic valve replacement in patients with malignancy. Cardiovasc Revasc Med 2021;23:59-65.
37. Forcillo J, Condado JF, Binongo JN, et al. Readmission rates after transcatheter aortic valve replacement in high- and extreme-risk patients with severe aortic stenosis. J Thorac Cardiovasc Surg 2017;154:445-52.
38. Sanchez CE, Hermiller JB Jr, Pinto DS, et al. Predictors and risk calculator of early unplanned hospital readmission following contemporary self-expanding transcatheter aortic valve replacement from the STS/ACC TVT registry. Cardiovasc Revasc Med 2020;21:263-70.
